Orange Book product · Generic (ANDA)
DUTASTERIDE
DUTASTERIDE
At a glance
Dec 21, 2010
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 21, 2010
15 yr 9 mo ago
Today
Pharmaceutical detail
Active ingredient
DUTASTERIDE
Strength
0.5MG
Dosage form
CAPSULE
Route
ORAL
TE code
AB
Application
ANDA 090095
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of DUTASTERIDE
- 2001AVODARTBrand (NDA)
NDA 021319 · WAYLIS THERAP
- 2018DUTASTERIDEGeneric (ANDA)
ANDA 208227 · STRIDES PHARMA
- 2017DUTASTERIDEGeneric (ANDA)
ANDA 209909 · HUMANWELL PURACAP
- 2017DUTASTERIDEGeneric (ANDA)
ANDA 207935 · HERITAGE PHARMS INC
- 2017DUTASTERIDEGeneric (ANDA)
ANDA 204373 · ZYDUS LIFESCIENCES
- 2017DUTASTERIDEGeneric (ANDA)
ANDA 204376 · ADAPTIS
- 2016DUTASTERIDEGeneric (ANDA)
ANDA 206574 · ASCENT PHARMS INC
- 2016DUTASTERIDEGeneric (ANDA)
ANDA 203241 · PHARMOBEDIENT
- 2016DUTASTERIDEGeneric (ANDA)
ANDA 206373 · ACELLA
- 2015DUTASTERIDEGeneric (ANDA)
ANDA 204292 · APOTEX
- 2015DUTASTERIDEGeneric (ANDA)
ANDA 202204 · HIKMA
- 2015DUTASTERIDEGeneric (ANDA)
ANDA 202808 · ACTAVIS LABS FL INC
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
